ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Applying to New York-Presbyterian/Brooklyn Methodist Hospital · Brooklyn, New York
Answer a few short questions to share with the research team.